CLINICAL OUTCOMES OF METASTATIC MELANOMA PATIENTS WITH LIVER METASTASES TREATED WITH ANTI-PD-1 MONOTHERAPY VERSUS COMBINATION IPILIMUMAB/NIVOLUMAB

被引:2
|
作者
Ma, Vincent [1 ]
Griffith, Kent [1 ]
Waninger, Jessica [1 ]
Daignault-Newton, Stephanie [1 ]
Fecher, Leslie [1 ]
Lao, Ajjai Alva Christopher [1 ]
机构
[1] Univ Michigan, Ann Arbor, MI 48109 USA
关键词
D O I
10.1136/jitc-2020-SITC2020.0241
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
241
引用
收藏
页码:A143 / A144
页数:2
相关论文
共 50 条
  • [1] Ipilimumab versus ipilimumab plus anti-PD-1 for metastatic melanoma
    Li, Mengqian
    LANCET ONCOLOGY, 2021, 22 (08): : E342 - E342
  • [2] The impact of BRAF mutation status on clinical outcomes with anti-PD-1 monotherapy versus combination ipilimumab/nivolumab in treatment-naive advanced stage melanoma
    Ma, Vincent T.
    Daignault-Newton, Stephanie
    Waninger, Jessica J.
    Journey, Sara
    Chopra, Zoey
    Tezel, Alangoya
    Redman, Bruce G.
    Fecher, Leslie A.
    Green, Michael D.
    Alva, Ajjai S.
    Lao, Christopher D.
    PIGMENT CELL & MELANOMA RESEARCH, 2021, 34 (03) : 629 - 640
  • [3] Ipilimumab versus ipilimumab plus anti-PD-1 for metastatic melanoma reply
    da Silva, Ines Pires
    Ahmed, Tasnia
    Reijers, Irene L. M.
    Warner, Allison Betof
    Patrinely, James Randall
    Serra-Bellver, Patricio
    Allayous, Clara
    Mangana, Joanna
    Zimmer, Lisa
    Trojaniello, Claudia
    Klein, Oliver
    Gerard, Camille L.
    Michielin, Olivier
    Haydon, Andrew
    Ascierto, Paolo A.
    Carlino, Matteo S.
    Lebbe, Celeste
    Lorigan, Paul
    Johnson, Douglas B.
    Sandhu, Shahneen
    Lo, Serigne N.
    Menzies, Alexander M.
    Long, Georgina, V
    LANCET ONCOLOGY, 2021, 22 (08): : E343 - E344
  • [4] Intracranial outcomes with ipilimumab and nivolumab in melanoma brain metastases following progression on anti-PD-1 therapy
    Lochrin, Sarah E.
    Kalvin, Hannah L.
    Smithy, James William
    Momtaz, Parisa
    Shoushtari, Alexander Noor
    Panageas, Katherine
    Postow, Michael A.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [5] Intracranial Outcomes of Ipilimumab and Nivolumab in Melanoma Brain Metastases After Progression on Anti-PD-1 Therapy
    Lochrin, Sarah E.
    Kalvin, Hannah L.
    Smithy, James W.
    Chen, Monica F.
    Momtaz, Parisa
    Shoushtari, Alexander N.
    Panageas, Katherine S.
    Postow, Michael A.
    JAMA ONCOLOGY, 2025,
  • [6] Anti-PD-1 (PD1) monotherapy or in combination with antiCTLA-4 for metastatic melanoma (MM) patients (pts) with liver metastases (mets)
    Pires da Silva, I.
    Li, I.
    Ugurel-Becker, S.
    Serra-Bellver, P.
    Andhale, A.
    Burnette, H.
    Aya, F.
    Conway, J.
    Carlino, M.
    Menzies, A. M.
    Weichenthal, M.
    Mohr, P.
    Gutzmer, R.
    Arance Fernandez, A. M.
    Johnson, D.
    Lorigan, P.
    Schadendorf, D.
    Lo, S.
    Long, G. V.
    ANNALS OF ONCOLOGY, 2023, 34 : S666 - S667
  • [7] Clinical outcomes of melanoma brain metastases treated with nivolumab and ipilimumab alone versus nivolumab and ipilimumab with stereotactic radiosurgery
    Tang, Joseph D.
    Mills, Matthew N.
    Nakashima, Justyn
    Dohm, Ammoren E.
    Khushalani, Nikhil I.
    Forsyth, Peter A.
    Vogelbaum, Michael A.
    Wuthrick, Evan J.
    Yu, Hsiang-Hsuan M.
    Oliver, Daniel E.
    Liu, James K. C.
    Ahmed, Kamran A.
    JOURNAL OF NEURO-ONCOLOGY, 2024, 166 (03) : 431 - 440
  • [8] Clinical outcomes of melanoma brain metastases treated with nivolumab and ipilimumab alone versus nivolumab and ipilimumab with stereotactic radiosurgery
    Joseph D. Tang
    Matthew N. Mills
    Justyn Nakashima
    Ammoren E. Dohm
    Nikhil I. Khushalani
    Peter A. Forsyth
    Michael A. Vogelbaum
    Evan J. Wuthrick
    Hsiang-Hsuan M. Yu
    Daniel E. Oliver
    James K. C. Liu
    Kamran A. Ahmed
    Journal of Neuro-Oncology, 2024, 166 : 431 - 440
  • [9] CLINICAL OUTCOMES OF MELANOMA BRAIN METASTASES TREATED WITH NIVOLUMAB AND IPILIMUMAB ALONE VERSUS NIVOLUMAB AND IPILIMUMAB WITH STEREOTACTIC RADIOSURGERY
    Tang, Joseph
    Mills, Matthew
    Dohm, Ammoren
    Khushalani, Nikhil
    Forsyth, Peter
    Vogelbaum, Michael A.
    Wuthrick, Evan
    Yu, Hsiang-Hsuan Michael
    Oliver, Daniel
    Liu, James
    Ahmed, Kamran
    NEURO-ONCOLOGY, 2023, 25
  • [10] Cost-Effectiveness of Ipilimumab Plus Anti-PD-1 Therapy Versus Ipilimumab Alone in Patients With Metastatic Melanoma Resistant to Anti-PD-(L)1 Monotherapy
    Peng, Ye
    Zeng, Xiaohui
    Peng, Liubao
    Liu, Qiao
    Yi, Lidan
    Luo, Xia
    Li, Sini
    Wang, Liting
    Qin, Shuxia
    Wan, Xiaomin
    Tan, Chongqing
    FRONTIERS IN ONCOLOGY, 2021, 11